NCT05104034

Brief Summary

The purpose of this project is:

  1. 1.Provide the epidemiological data of the prevalence, incidence, and risk factors of osteoporosis and sarcopenia among the elderly in rural areas.
  2. 2.Screen osteoporosis and sarcopenia among the elderly and provide with assistance for following care in order to improve the diagnosis and treatment rates of osteoporosis and sarcopenia
  3. 3.Construct a pragmatic and integrated care service model for osteoporosis and sarcopenia in the elderly people from rural areas

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 2, 2021

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 15, 2024

Status Verified

September 1, 2023

Enrollment Period

4.3 years

First QC Date

October 11, 2021

Last Update Submit

April 11, 2024

Conditions

Keywords

OsteoporosisSarcopeniaQuality of lifeIntrinsic capacityFrailty

Outcome Measures

Primary Outcomes (3)

  • The changes of Quality of life and quality adjusted life year

    Using EQ5D / WHOQOL Brief questionnaires to measure quality of life and evaluate the changes after intervention. In addition, to calculate quality adjusted life year by using utility index derived from qualify of life measurement.

    one year, two year, 3 year, four year

  • Intrinsic capacity

    To define if the Intrinsic capacity would be changed after intervention

    one year, two year, 3 year, four year

  • Institutionalilzation rate

    To define if the Institutionalilzation rate would be changed after intervention

    one year, two year, 3 year, four year

Secondary Outcomes (3)

  • Incidence of fall

    one year, two year, 3 year, four year

  • Incidence of fracture

    one year, two year, 3 year, four year

  • Incidence of unexpected hospitalization

    one year, two year, 3 year, four year

Other Outcomes (8)

  • Incidence of mortality

    one year, two year, 3 year, four year

  • Changes of drug related problems

    one year, two year, 3 year, four year

  • Phyiscal performance

    one year, two years

  • +5 more other outcomes

Study Arms (3)

Screening group

EXPERIMENTAL

Inform the elderly about the results of the screening and recommend those with moderate to high risk of fracture to receive active examination and treatment.

Behavioral: Osteoporosis screening and treatment as needed

Multi-component integrated intervention

EXPERIMENTAL

Introduce integrated services of health education, nutrition, rehabilitation, pharmaceutical care, and other multi-specialties to assist study participants with health promotion

Behavioral: Osteoporosis screening and treatment as neededBehavioral: SarcopeniaBehavioral: ExerciseDietary Supplement: NutritionBehavioral: Pharmaceutical care

Delayed intervention

PLACEBO COMPARATOR

receive general care after collecting basic information, and provide health education related information such as osteoporosis sarcopenia. After two year's follow-up, multi-disciplinary team intervention service will be implemented.

Behavioral: Osteoporosis screening and treatment as needed

Interventions

All residents underwent screening using the Fracture Risk Assessment Tool (FRAX) and Mobile dual-energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic Inc., Bedford, MA). Our study nurses actively assisted osteoporosis treatment if indicated.

Delayed interventionMulti-component integrated interventionScreening group
SarcopeniaBEHAVIORAL

Sarcopenia assessment adhered to the 2019 Consensus Update on Sarcopenia Diagnosis and Treatment by the Asian Working Group for Sarcopenia guideline. Following screening, individuals identified with sarcopenia underwent tailored interventions involving exercise and nutrition as deemed necessary.

Multi-component integrated intervention
ExerciseBEHAVIORAL

TheraBand (resistance band) was utilized as the exercise tool within the community. T

Multi-component integrated intervention
NutritionDIETARY_SUPPLEMENT

Nutrition Nutritional education programs aim to increase protein food serving and the choice of those with insufficient dietary intake. Protein supplement was added if indicated.

Multi-component integrated intervention

We collected drug information of the elderly. Detailed and real-time prescription drug information was retrieved from the National Health Insurance PharmaCloud System. A pharmaceutical care team performed patient-centered drug review and discussion every three to six months.

Multi-component integrated intervention

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥ 50 old and lived in the community

You may not qualify if:

  • Life expectancy less than two years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital, Yunlin branch

Douliu, Yunlin County, Taiwan

RECRUITING

Related Publications (1)

  • Fu SH, Lai WJ, Yen HK, Kukreti S, Li CY, Hung CC, Wang CY. Addressing healthcare disparities and improving osteoporosis management in rural communities: a cluster randomized control trial. Arch Osteoporos. 2025 Jan 28;20(1):15. doi: 10.1007/s11657-025-01498-4.

MeSH Terms

Conditions

OsteoporosisSarcopeniaFrailty

Interventions

TherapeuticsHealth Services Needs and DemandExerciseNutritional StatusPharmaceutical Services

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

Health Services ResearchHealth PlanningHealth Care Economics and OrganizationsDelivery of Health CareHealth Care Quality, Access, and EvaluationMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation CharacteristicsHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Shau-Huai Fu, Doctor

CONTACT

Chen-Yu Wang, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2021

First Posted

November 2, 2021

Study Start

September 17, 2021

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 15, 2024

Record last verified: 2023-09

Locations